CareDx, Inc (CDNA)
After hours:
| Previous Close | 44.20 |
| Open | 44.26 |
| Bid | 45.90 x 1400 |
| Ask | 50.40 x 1100 |
| Day's Range | 42.98 - 46.71 |
| 52 Week Range | 39.16 - 99.83 |
| Volume | |
| Avg. Volume | 730,059 |
| Market Cap | 2.422B |
| Beta (5Y Monthly) | 0.56 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 |
| Earnings Date | Feb. 22, 2022 - Feb. 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 99.33 |
- GlobeNewswire
CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CareDx, Inc. (“CareDx” or the “Company”) (NASDAQ: CDNA) on behalf of CareDx stockholders. Our investigation concerns whether CareDx has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On January 25, 2021, the Company sold 1,923,077 shares of its com
- GlobeNewswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. Visit: http://www.hbsslaw.com/investor-fraud/CDNA Contact An Attorney Now: CDNA@hbsslaw.com 844-916-0895 CareDx, Inc. (CDNA) Investigation: The investigation centers on the accuracy of CareDx’s statements concerning its business practices, accounting, and public reporting, particularly pertaining to the company’s kidney testing and phleb
- Newsfile
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CareDx, Inc ("CareDx" or "the Company") (NASDAQ: CDNA) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. CareDx released its Q3 2021 results on October 28, 2021
